Table 5.
Comparison of therapeutic efficacy in the fistuloclysis subgroups.
| Group 1 | Group 2 | Group 3 | |
|---|---|---|---|
| (n = 11) | (n = 16) | (n = 8) | |
| TB (μmol/L) | ■ | ● | |
| DB (μmol/L) | ■ | ● | |
| IB (μmol/L) | ■ | ● | |
| ALT (U/L) | ● | ■ | |
| ALP (U/L) | ■ | ● | |
| GGT (U/L) | |||
| TP (g/L) | ■ | ● | |
| Alb (g/L) | ■ | ● | |
| WBC (109/L) | |||
| CRP (mg/L) | |||
| Fistula output (mL/day) | |||
Group 1: patients with jejunal-ileal fistula; Group 2: patients with biliary fistula; Group 3: patients with duodenal fistula. TB: total bilirubin; DB: direct bilirubin; IB: indirect bilirubin; ALT: alanine aminotransferase; ALP: alkaline phosphatase; GGT: γ-glutamyltransferase; TP: total protein; Alb: albumin; WBC: white blood cells; CRP: C-reactive protein. For each laboratory variable, patients who had the greatest changes were marked with ●. Conversely, patients with the least changes were marked with ■.